Overview
This is a multicenter, open-label phase I/II study for the first-line treatment of advanced cervical cancer.
Eligibility
Inclusion Criteria:
- Fully understand the study and voluntarily sign the informed consent form.
- Female 18-70 years of age;
- Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or
- Life expectancy ≥ 3 months.
Exclusion Criteria:
- Patients were deemed unsuitable for participating in the study by the investigator for any reasons.